Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
Kate Therapeutics has raised $21.8M in total funding. The most recent round was Series B. The last funding was announced in August 2024.
Kate Therapeutics's investors include Versant Ventures, OUP (Osage University Partners), Westlake Village BioPartners, UF Innovate Ventures.
Kate Therapeutics is headquartered in San Diego, United States.
Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
Kate Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kate Therapeutics — Funding & Investors." VCBacked, August 7, 2024, https://www.vcbacked.co/company/kate-therapeutics. Accessed July 27, 2026.
VCBacked. (2024). Kate Therapeutics — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/kate-therapeutics
{{cite web |title=Kate Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kate-therapeutics |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated